期刊文献+

2型糖尿病正常糖耐量一级亲属抗氧化能力的研究 被引量:3

Antioxidant capacity in patients with type 2 diabetes and their first-degree relatives with normal glucose tolerance
原文传递
导出
摘要 目的观察2型糖尿病患者及其正常糖耐量一级亲属抗氧化能力的改变。方法随机选取58例2型糖尿病患者作为糖尿病组;72例上述患者正常糖耐量一级亲属作为观察组;年龄、性别和体质量指数匹配、无糖尿病家族史的35例健康志愿者作为对照组。比较各组的超氧化物歧化酶(SOD)、丙二醛(MDA)、一氧化氮(NO)、谷胱甘肽过氧化物酶(GSH-PX)、总抗氧化能力(T-AOS)的改变。结果与对照组相比,糖尿病组SOD、NO、GSH-PX和T-AOS明显降低(P<0.05),MDA明显升高(P<0.05)。观察组的SOD有降低趋势(P=0.058),MDA有升高趋势(P=0.052),NO、GSH-PX、T-AOS无明显变化。结论2型糖尿病患者抗氧化能力明显降低,其正常糖耐量一级亲属抗氧化能力亦有降低趋势。 Objective To investigate the changes of antioxidant ability in patients with type 2 diabetes mellitus and their normoglycemic first-degree relatives. Methods 58 patients with type 2 diabetes mellitus were selected as the diabetes group, 72 normoglycemic first-degree relatives as the observation group, and 35 healthy controls without a diabetic family history matched for age, sex and body mass index as the control group. Changes of superoxide dismutase (SOD), maleic dialdehyde( MDA), nitric oxide( NO), glutathione peroxidase(GSH-PX) and total antioxidant status(T-AOS) were compared. Results SOD, NO, GSH-PX and T-AOS were significantly lower (P 〈 0. 05 ) and MDA was higher ( P 〈 0. 05 ) in the diabetic group compared with those in the control group; SOD showed an increasing trend ( P = 0. 058 ) and MDA showed a decreasing trend ( P = 0. 052 ) in the observation group. But NO, GSH-PX and T-AOS had no significant changes. Conclusions Antioxidant ability significantly declines in patients with type 2 diabetes mellitus, and also shows a declining trend in their normoglycemic first-degree relatives.
出处 《山东大学学报(医学版)》 CAS 北大核心 2010年第2期10-13,共4页 Journal of Shandong University:Health Sciences
关键词 糖尿病 非胰岛素依赖型 一级亲属 抗氧化能力 Diabetes mellitus, non-insullin dependent First-degree relatives Anfioxidant ability
  • 相关文献

参考文献11

  • 1Nishikawa T, Edelstein D, Du X L, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage [ J ]. Nature, 2000, 404 ( 6779 ) : 787 -790.
  • 2Kaneto H, Xu G, Song K H, et al. Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function through the induction of oxidative stress [ J ]. J Biol Chem, 2001, 276(33):31099-31104.
  • 3宋稚牛.中国糖尿病流行病学[M]//蒋国彦.实用糖尿病学.北京:人民卫生出版社,1992:2248.
  • 4Groop L, Forsblom C, Lehtovirta M. Characterization of theabetic state [J]. Am JHypertens, 1997, 10(9) : 172- 180.
  • 5邓晨昕,高凌,张海荣,曾照琼.2型糖尿病患者非糖尿病一级亲属血清高敏C反应蛋白与胰岛素抵抗的相关性[J].中国糖尿病杂志,2008,16(7):413-415. 被引量:6
  • 6Sles H, Brigelius R, Weers H, et al. Cellular redox changes and response to drugs andtoxic agents [J]. Fundam Appl Toxied, 1983, 3(4) :200-208.
  • 7Nishikawa T, Sasahara T, Kiritoshi S, et al. Evaluation of urinary 8 hydroxydeoxyguanosine as a novel biomarker of macrovascular complications in type 2 diabetes [ J ]. Diabetes Care, 2003, 26(5) :1507-1512.
  • 8王丽宏,艾静,张巾超,李强,杨梅,杨宝峰.不同糖耐量者血清丙二醛及超氧化物歧化酶水平的变化[J].中国实用内科杂志,2005,25(4):311-312. 被引量:14
  • 9Fridlyand L E, Philipson L H. Reactive species and earlymanifestation of insulin resistance in type 2 diabetes [J]. Diabetes Obes Metab, 2006, 8(2) :156-145.
  • 10Robertson R P, Harmon J, Tran P O, et al. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection [ J ]. Diabetes, 2003, 52(3 ) :581-587.

二级参考文献9

  • 1姚军,郭晓蕙,张俊清,惠岩,陈澜.2型糖尿病患者应用吡格列酮治疗前后血清C反应蛋白的改变[J].中华糖尿病杂志(1006-6187),2005,13(3):209-212. 被引量:22
  • 2陈忠,马根山,冯毅,严金川,罗丹,沈成兴,戴启明.男性早发稳定型心绞痛患者血浆瘦素、C反应蛋白和胰岛素抵抗的相关性研究[J].中国糖尿病杂志,2006,14(3):169-170. 被引量:3
  • 3Maddux BA, See W, Lawrence JC Jr, et al. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes,2001,50 ( 2 ) :404410.
  • 4Steppan CM,Bailey ST,Bhat S,et al. The hormone resistin links obesity to diabetes. Nature,2001,409 (6818) :307-312.
  • 5Evans JL, Goldfine ID. α-Lipoic acid:a multi-functional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther,2000,2(3) :401-413.
  • 6Nakanishi S, Yamane K, Kamei N,et al. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care, 2003,26: 2754-2757.
  • 7Mita T, Watada H . Uchino H . et al. Association of C-reactive Protein with Early-stage Carotid Atherosclerosis in Japanese Patients with Early-state Type 2 Diabetes Mellitus. Endocrine Journal. 2006,53 :693-698.
  • 8Laaksonen DE, Niskanen L, Nyyssonen K, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia, 2004,47 : 1403-1410.
  • 9朱大龙,胡云,韩光晓,顾经宇.2型糖尿病患者正常糖代谢一级亲属胰岛素抵抗及其相关因素分析[J].中国糖尿病杂志,2004,12(1):9-13. 被引量:11

共引文献18

同被引文献64

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部